In this section
@article{Prendecki:2018:10.3899/jrheum.170661,
author = {Prendecki, M and Martin, L and Tanna, A and Antonelou, M and Pusey, CD},
doi = {10.3899/jrheum.170661},
journal = {Journal of Rheumatology},
title = {Increased prevalence of thyroid disease in patients with antineutrophil cytoplasmic antibodies-associated vasculitis},
url = {http://dx.doi.org/10.3899/jrheum.170661},
volume = {45},
year = {2018}
}
TY - JOUR
AB - OBJECTIVE: Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) has been linked with thyroid disease as a result of antithyroid medications. We assessed the prevalence of thyroid disease in our patients with AAV. METHODS: Clinical records of 279 patients with AAV diagnosed between 1991 and 2014 were analyzed. RESULTS: Thyroid disease was identified in 21.5% of patients, but only 2 had previously received propylthiouracil. There was a greater proportion of female patients, patients with antimyeloperoxidase antibodies, and patients with renal disease in the group with thyroid disease. CONCLUSION: Our data show a higher prevalence of thyroid disease in patients with AAV than the general population. This was not attributable to antithyroid drugs.
AU - Prendecki,M
AU - Martin,L
AU - Tanna,A
AU - Antonelou,M
AU - Pusey,CD
DO - 10.3899/jrheum.170661
PY - 2018///
SN - 0315-162X
TI - Increased prevalence of thyroid disease in patients with antineutrophil cytoplasmic antibodies-associated vasculitis
T2 - Journal of Rheumatology
UR - http://dx.doi.org/10.3899/jrheum.170661
UR - https://www.ncbi.nlm.nih.gov/pubmed/29545453
UR - http://hdl.handle.net/10044/1/58230
VL - 45
ER -
For any questions related to the Centre, please contact:
Vasculitis Centre of Excellence Admin
VasculitisCoE@imperial.ac.uk
